Ethambutol potentiates extracellular and intracellular activities of clarithromycin, sparfloxacin, amikacin, and rifampin againstMycobacterium avium
- 1 April 1993
- journal article
- Published by Springer Nature in Current Microbiology
- Vol. 26 (4) , 191-196
- https://doi.org/10.1007/bf01577376
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Survival of Patients with Acquired Immune Deficiency Syndrome and DisseminatedMycobacterium aviumComplex Infection with and without Antimycobacterial ChemotherapyAmerican Review of Respiratory Disease, 1991
- Mycobacterium aviumComplex Infection in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1991
- Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complexAntimicrobial Agents and Chemotherapy, 1991
- Pharmacokinetics of a novel quinolone, AT-4140, in animalsAntimicrobial Agents and Chemotherapy, 1990
- Killing intracellular mycobacteria in in vitro macrophage systems: What may be the role of known host microbicidal mechanisms?Research in Microbiology, 1990
- New directions for macrolide antibiotics: pharmacokinetics and clinical efficacyAntimicrobial Agents and Chemotherapy, 1989
- In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinoloneAntimicrobial Agents and Chemotherapy, 1989
- Ethambutol: A Key forMycobacterium AviumComplex Chemotherapy?American Review of Respiratory Disease, 1989
- Amikacin, ciprofloxacin, and imipenem treatment for disseminated Mycobacterium avium complex infection of beige miceAntimicrobial Agents and Chemotherapy, 1989
- Mechanisms of pathogenicity in mycobacteriaBiochimie, 1988